Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003871208 | SCV004680874 | benign | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004369623 | SCV004926770 | uncertain significance | Inborn genetic diseases | 2023-11-28 | criteria provided, single submitter | clinical testing | The c.4692T>G (p.D1564E) alteration is located in exon 63 (coding exon 63) of the COL11A1 gene. This alteration results from a T to G substitution at nucleotide position 4692, causing the aspartic acid (D) at amino acid position 1564 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV003871208 | SCV005331404 | uncertain significance | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | COL11A1: PM2, BP4 |